Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 1 , Pages 41-55 , February 2008

Insulin and carbohydrate metabolism

  • Kathryn Beardsall, MRCP (Clinical Lecturer)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +44 1223 763 404; Fax: +44 1223 336 996.

References 

  1. Economides DL, Proudler A, Nicolaides KH. Plasma insulin in appropriate- and small-for-gestational-age fetuses. American Journal of Obstetrics and Gynecology. 1989;160:1091–1094
  2. Hill DJ, Petrik J, Arany E. Growth factors and the regulation of fetal growth. Diabetes Care. 1998;21(supplement 2):B60–B69
  3. Hill DJ, Duvillie B. Pancreatic development and adult diabetes. Pediatric Research. 2000;48:269–274
  4. Hay WW, Sparks JW. Placental, fetal, and neonatal carbohydrate metabolism. Clinical Obstetrics and Gynecology. 1985;28:473–485
  5. Ong K, Kratzsch J, Kiess W, et al. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. The Journal of Clinical Endocrinology and Metabolism. 2000;85:4266–4269
  6. Kliegman RM. Intrauterine Growth Retardation. In:  Fanaroff AA,  Martin RJ editor. Neonatal-perinatal medicine:diseases of the fetus and neonate. 6 edn. St. Louis, Mo: Mosby; 1997;p. 203–240
  7. Kalhan SC, D'Angelo LJ, Savin SM, et al. Glucose production in pregnant women at term gestation. Sources of glucose for human fetus. Journal of Clinical Investigation. 1979;63:388–394
  8. Catalano PM, Tyzbir ED, Wolfe RR, et al. Carbohydrate metabolism during pregnancy in control subjects and women with gestational diabetes. American Journal of Physiology. 1993;264:E60–E67
  9. Boden G. Fuel metabolism in pregnancy and in gestational diabetes mellitus. Obstetrics and Gynecology Clinics of North America. 1996;23:1–10
  10. Kalhan S, Rossi K, Gruca L, et al. Glucose turnover and gluconeogenesis in human pregnancy. Journal of Clinical Investigation. 1997;100:1775–1781
  11. Illsley NP. Glucose transporters in the human placenta. Placenta. 2000;21:14–22
  12. Hay WW, Meznarich HK. Effect of maternal glucose concentration on uteroplacental glucose consumption and transfer in pregnant sheep. Proceedings of the Society for Experimental Biology and Medicine. 1989;190:63–69
  13. Gaither K, Quraishi AN, Illsley NP. Diabetes alters the expression and activity of the human placental GLUT1 glucose transporter. Journal of Clinical Endocrinology and Metabolism. 1999;84:695–701
  14. Esterman A, Greco MA, Mitani Y, et al. The effect of hypoxia on human trophoblast in culture: morphology, glucose transport and metabolism. Placenta. 1997;18:129–136
  15. Hahn T, Barth S, Graf R, et al. Placental glucose transporter expression is regulated by glucocorticoids. The Journal of Clinical Endocrinology and Metabolism. 1999;84:1445–1452
  16. Hay WW, Meznarich HK, DiGiacomo JE, et al. Effects of insulin and glucose concentrations on glucose utilization in fetal sheep. Pediatric Research. 1988;23:381–387
  17. Ostlund I, Hanson U, Bjorklund A, et al. Maternal and fetal outcomes if gestational impaired glucose tolerance is not treated. Diabetes Care. 2003;26:2107–2111
  18. Metzger BE, Coustan DR. Summary and recommendations of the Fourth International Workshop-Conference on Gestational Diabetes Mellitus. The Organizing Committee. Diabetes Care. 1998;21(supplement 2):B161–B167
  19. Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. The New England Journal of Medicine. 2005;352:2477–2486
  20. Chen R, Yogev Y, Ben-Haroush A, et al. Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus. The Journal of Maternal-Fetal and Neonatal Medicine. 2003;14:256–260
  21. Yogev Y, Chen R, Ben-Haroush A, et al. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstetrics and Gynecology. 2003;101:633–638
  22. Buhling KJ, Winkel T, Wolf C, et al. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS). Journal of Perinatal Medicine. 2005;33:125–131
  23. Murphy H, Rayman G, Duffield K, et al. Changes in the glycaemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care. 2007;30:2785–2791
  24. Ben-Haroush A, Yogev Y, Chen R, et al. The postprandial glucose profile in the diabetic pregnancy. American Journal of Obstetrics and Gynecology. 2004;191:576–581
  25. Yogev Y, Ben-Haroush A, Chen R, et al. Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. American Journal of Obstetrics and Gynecology. 2004;191:949–953
  26. Jovanovic-Peterson L, Peterson CM, Reed GF, et al. Maternal postprandial glucose levels and infant birth weight: the Diabetes in Early Pregnancy Study. The National Institute of Child Health and Human Development–Diabetes in Early Pregnancy Study. American Journal of Obstetrics and Gynecology. 1991;164:103–111
  27. Kitzmiller JL, Buchanan TA, Kjos S, et al. Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care. 1996;19:514–541
  28. Moore LL, Singer MR, Bradlee ML, et al. A prospective study of the risk of congenital defects associated with maternal obesity and diabetes mellitus. Epidemiology. 2000;11:689–694
  29. Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstetrics and Gynecology. 2003;102:857–868
  30. Lauenborg J, Mathiesen E, Ovesen P, et al. Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care. 2003;26:1385–1389
  31. Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. Journal of Clinical Endocrinology and Metabolism. 1988;67:341–347
  32. Catalano PM, Kirwan JP, Haugel-de Mouzon S, et al. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. Journal of Nutrition. 2003;133:1674S–1683S
  33. Ktorza A, Bihoreau MT, Nurjhan N, et al. Insulin and glucagon during the perinatal period: secretion and metabolic effects on the liver. Biology of the Neonate. 1985;48:204–220
  34. Fowden AL, Hughes P, Comline RS. The effects of insulin on the growth rate of the sheep fetus during late gestation. Quarterly Journal of Experimental Physiology. 1989;74:703–714
  35. Oliver MH, Harding JE, Breier BH, et al. Fetal insulin-like growth factor (IGF)-I and IGF-II are regulated differently by glucose or insulin in the sheep fetus. Reproduction Fertility and Development. 1996;8:167–172
  36. Lampl M, Jeanty P. Exposure to maternal diabetes is associated with altered fetal growth patterns: A hypothesis regarding metabolic allocation to growth under hyperglycemic-hypoxemic conditions. American Journal of Human Biology. 2004;16:237–263
  37. Homko CJ, Reece EA. Insulins and oral hypoglycemic agents in pregnancy. The Journal of Maternal-Fetal and Neonatal Medicine. 2006;19:679–686
  38. Gimenez M, Conget I, Nicolau J, et al. Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study. Acta Diabetologica. 2007;44:34–37
  39. Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Human Reproduction. 2004;19:1644–1646
  40. Kristensen J, Vestergaard M, Wisborg K, et al. Pre-pregnancy weight and the risk of stillbirth and neonatal death. BJOG. 2005;112:403–408
  41. Orskou J, Henriksen TB, Kesmodel U, et al. Maternal characteristics and lifestyle factors and the risk of delivering high birth weight infants. Obstetrics and Gynecology. 2003;102:115–120
  42. Surkan PJ, Hsieh CC, Johansson AL, et al. Reasons for increasing trends in large for gestational age births. Obstetrics and Gynecology. 2004;104:720–726
  43. Waller DK, Mills JL, Simpson JL, et al. Are obese women at higher risk for producing malformed offspring?. American Journal of Obstetrics and Gynecology. 1994;170:541–548
  44. Cedergren MI, Kallen BA. Maternal obesity and infant heart defects. Obesity Research. 2003;11:1065–1071
  45. Volcik KA, Shaw GM, Zhu H, et al. Risk factors for neural tube defects: associations between uncoupling protein 2 polymorphisms and spina bifida. Birth Defects Research. Part A, Clinical and Molecular Teratology. 2003;67:158–161
  46. Volcik KA, Shaw GM, Zhu H, et al. Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Research. Part A, Clinical and Molecular Teratology. 2003;67:924–928
  47. Huang DY, Usher RH, Kramer MS, et al. Determinants of unexplained antepartum fetal deaths. Obstetrics and Gynecology. 2000;95:215–221
  48. Nohr EA, Bech BH, Davies MJ, et al. Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstetrics and Gynecology. 2005;106:250–259
  49. Weiss JL, Malone FD, Emig D, et al. Obesity, obstetric complications and cesarean delivery rate–a population-based screening study. American Journal of Obstetrics and Gynecology. 2004;190:1091–1097
  50. Sivan E, Chen X, Homko CJ, et al. Longitudinal study of carbohydrate metabolism in healthy obese pregnant women. Diabetes Care. 1997;20:1470–1475
  51. Catalano PM, Huston L, Amini SB, et al. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. American Journal of Obstetrics and Gynecology. 1999;180:903–916
  52. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. American Journal of Clinical Nutrition. 2000;71:1256S–1261S
  53. Langer O, Yogev Y, Xenakis EM, et al. Overweight and obese in gestational diabetes: the impact on pregnancy outcome. American Journal of Obstetrics and Gynecology. 2005;192:1768–1776
  54. Metzger BE. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. International Journal of Gynaecology and Obstetrics. 2002;78:69–77
  55. Economides DL, Nicolaides KH. Blood glucose and oxygen tension levels in small-for-gestational-age fetuses. American Journal of Obstetrics and Gynecology. 1989;160:385–389
  56. Sperling MA, DeLamater PV, Phelps D, et al. Spontaneous and amino acid-stimulated glucagon secretion in the immediate postnatal period. Relation to glucose and insulin. The Journal of Clinical Investigation. 1974;53:1159–1166
  57. Sperling MA, Ganguli S, Leslie N, et al. Fetal-perinatal catecholamine secretion: role in perinatal glucose homeostasis. American Journal of Psychology. 1984;247:E69–E74
  58. Girard JR, Caquet D, Bal D, et al. Control of rat liver phosphorylase, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase activities by insulin and glucagon during the perinatal period. Enzyme. 1973;15:272–285
  59. Hume R, Burchell A. Abnormal expression of glucose-6-phosphatase in preterm infants. Archives of Disease in Childhood. 1993;68:202–204
  60. Marcus C, Ehren H, Bolme P, et al. Regulation of lipolysis during the neonatal period. Importance of thyrotropin. The Journal of Clinical Investigation. 1988;82:1793–1797
  61. Lucas A, Bloom SR, Aynsley-Green A. Metabolic and endocrine events at the time of the first feed of human milk in preterm and term infants. Archives of Disease in Childhood. 1978;53:731–736
  62. Scaglia L, Cahill CJ, Finegood DT, et al. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology. 1997;138:1736–1741
  63. Petrik J, Arany E, McDonald TJ, et al. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology. 1998;139:2994–3004
  64. Petrik J, Pell JM, Arany E, et al. Overexpression of insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology. 1999;140:2353–2363
  65. Kassem SA, Ariel I, Thornton PS, et al. Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes. 2000;49:1325–1333
  66. Catalano PM, Drago NM, Amini SB. Maternal carbohydrate metabolism and its relationship to fetal growth and body composition. American Journal of Obstetrics and Gynecology. 1995;172:1464–1470
  67. Artal R, Doug N, Wu P, et al. Circulating catecholamines and glucagon in infants of strictly controlled diabetic mothers. Biology of the Neonate. 1988;53:121–125
  68. Sunehag A, Ewald U, Larsson A, et al. Attenuated hepatic glucose production but unimpaired lipolysis in newborn infants of mothers with diabetes. Pediatric Research. 1997;42:492–497
  69. Lagercrantz H, Bistoletti P. Catecholamine release in the newborn infant at birth. Pediatric Research. 1977;11:889–893
  70. Akinbi HT, Gerdes JS. Macrosomic infants of nondiabetic mothers and elevated C-peptide levels in cord blood. The Journal of Pediatrics. 1995;127:481–484
  71. Schaefer-Graf UM, Rossi R, Buhrer C, et al. Rate and risk factors of hypoglycemia in large-for-gestational-age newborn infants of nondiabetic mothers. American Journal of Obstetrics and Gynecology. 2002;187:913–917
  72. Ahlsson F, Diderholm B, Ewald U, et al. Lipolysis and Insulin Sensitivity at Birth in Infants Who are Large for Gestational Age. Pediatrics. 2007;120:958–965
  73. Hawdon J, Ward Platt M. Metabolic adaption in small for gestational age infants. Archives of Disease in Childhood. 1993;68:262–268
  74. Garofano A, Czernichow P, Breant B. In utero undernutrition impairs rat beta-cell development. Diabetologia. 1997;40:1231–1234
  75. Van Assche FA, De Prins F, Aerts L, et al. The endocrine pancreas in small-for-dates infants. British Journal of Obstetrics and Gynaecology. 1977;84:751–753
  76. Beringue F, Blondeau B, Castellotti MC, et al. Endocrine pancreas development in growth-retarded human fetuses. Diabetes. 2002;51:385–391
  77. Limesand SW, Jensen J, Hutton JC, et al. Diminished beta-cell replication contributes to reduced beta-cell mass in fetal sheep with intrauterine growth restriction. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2005;288:R1297–R1305
  78. Dahri S, Snoeck A, Reusens-Billen B, et al. Islet function in offspring of mothers on low protein diet during gestation. Diabetes. 1991;40:115–120
  79. Setia S, Sridhar MG, Bhat V, et al. Insulin sensitivity and insulin secretion at birth in intrauterine growth retarded infants. Pathology. 2006;38:236–238
  80. Bazaes RA, Salazar TE, Pittaluga E, et al. Glucose and lipid metabolism in small for gestational age infants at 48 hours of age. Pediatrics. 2003;111:804–809
  81. Wang X, Cui Y, Tong X, et al. Glucose and lipid metabolism in small-for-gestational-age infants at 72 hours of age. The Journal of Clinical Endocrinology and Metabolism. 2007;92:681–684
  82. Ogilvy-Stuart AL, Hands SJ, Adcock CJ, et al. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein-1, growth hormone, and feeding in the newborn. The Journal of Clinical Endocrinology and Metabolism. 1998;83:3550–3557
  83. Keshen T, Miller R, Jahoor F, et al. Glucose production and gluconeogenesis are negatively related to body weight in mechanically ventilated, very low birth weight neonates. Pediatric Research. 1997 Jan;41(1):132–138
  84. Hawdon JM, Ward Platt MP, Aynsley-Green A. Patterns of metabolic adaptation for preterm and term infants in the first neonatal week. Archives of Disease in Childhood. 1992;67:357–365
  85. Haymond MW, Karl IE, Pagliara AS. Increased gluconeogenic substrates in the small-for-gestational-age infant. The New England Journal of Medicine. 1974;291:322–328
  86. Van Kempen AA, Romijn JA, Ruiter AF, et al. Adaptation of glucose production and gluconeogenesis to diminishing glucose infusion in preterm infants at varying gestational ages. Pediatric Research. 2003;53:628–634
  87. Beardsall K, Ogilvy-Stuart AL, Ahluwalia J, et al. The continuous glucose monitoring sensor in neonatal intensive care. Archives of Disease in Childhood. Fetal and Neonatal Edition. 2005;90:F307–F310
  88. Hawdon JM, Aynsley-Green A, Alberti KG, et al. The role of pancreatic insulin secretion in neonatal glucoregulation. I. Healthy term and preterm infants. Archives of Disease in Childhood. 1993;68:274–279
  89. Mitanchez-Mokhtari D, Lahlou N, Kieffer F, et al. Both relative insulin resistance and defective islet beta-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants. Pediatrics. 2004;113:537–541
  90. Aynsley-Green A. The endocrinology of feeding in the newborn. Baillière's Clinical Endocrinology and Metabolism. 1989;3:837–868
  91. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007;132:2131–2157
  92. Farrag HM, Nawrath LM, Healey JE, et al. Persistent glucose production and greater peripheral sensitivity to insulin in the neonate vs. the adult. American Journal of Psychology. 1997;272:E86–E93
  93. Goldman SL, Hirata T. Attenuated response to insulin in very low birthweight infants. Pediatric Research. 1980;14:50–53
  94. Ogata ES. Carbohydrate Homeostasis. In:  Avery GB,  Fletcher MA,  MacDonald MG editor. Neonatology Pathophysiology and Management of the Newborn. 5 edn. Philadelphia: Lippincott Williams&Wilkins; 1999;p. 699–714
  95. Hey E. Hyperglycaemia and the very preterm baby. Seminars in Fetal and Neonatal Medicine. 2005;10:377–387
  96. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Critical Care Clinics. 2001;17:107–124
  97. Latham R, Lancaster AD, Covington JF, et al. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infection Control and Hospital Epidemiology. 2001;22:607–612
  98. Guvener M, Pasaoglu I, Demircin M, et al. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. Endocrine Journal. 2002;49:531–537
  99. Gore DC, Chinkes D, Heggers J, et al. Association of hyperglycemia with increased mortality after severe burn injury. The Journal of Trauma. 2001;51:540–544
  100. Finberg L. Dangers to infants caused by changes in osmolal concentration. Pediatrics. 1967;40:1031–1034
  101. Hays SP, Smith EO, Sunehag AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics. 2006;118:1811–1818
  102. Kao LS, Morris BH, Lally KP, et al. Hyperglycemia and morbidity and mortality in extremely low birth weight infants. Journal of Perinatology. 2006;
  103. Beardsall K, Ogilvy-Stuart AL, Frystyk J, et al. Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-I levels in very low birth weight infants. The Journal of Pediatrics. 2007;151:611–617
  104. Collins JW, Hoppe M, Brown K, et al. A controlled trial of insulin infusion and parentral nutrition in extremely low birth weight infants with glucose intolerance. The Journal of Pediatrics. 1991;118:921–927
  105. Meetze W, Bowsher R, Compton J, et al. hyperglycaemia in extremely-low birth weight infants. Biology of the Neonate. 1998;74:214–221
  106. Hellström A, Engström E, Hård AL, et al. Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth. Pediatrics. 2003 Nov;112(5):1016–1020
  107. Sobngwi E, Boudou P, Mauvais-Jarvis F, et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet. 2003;361:1861–1865
  108. Hunter WA, Cundy T, Rabone D, et al. Insulin sensitivity in the offspring of women with type 1 and type 2 diabetes. Diabetes Care. 2004;27:1148–1152
  109. Pettitt DJ, Bennett PH, Saad MF, et al. Abnormal glucose tolerance during pregnancy in Pima Indian women. Long-term effects on offspring. Diabetes. 1991;40(supplement 2):126–130
  110. Dabelea D, Hanson RL, Lindsay RS, et al. Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships. Diabetes. 2000;49:2208–2211
  111. Ekelund U, Ong KK, Linne Y, et al. Association of Weight Gain in Infancy and Early Childhood with Metabolic Risk in Young Adults. The Journal of Clinical Endocrinology and Metabolism. 2007;92:98–103
  112. Li H, Stein AD, Barnhart HX, et al. Associations between prenatal and postnatal growth and adult body size and composition. American Journal of Clinical Nutrition. 2003;77:1498–1505
  113. Franks PW, Looker HC, Kobes S, et al. Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring. Diabetes. 2006;55:460–465
  114. Hales CN, Barker DJ, Clark PM, et al. Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 1991;303:1019–1022
  115. Hofman PL, Regan F, Jackson WE, et al. Premature birth and later insulin resistance. The New England Journal of Medicine. 2004;351:2179–2186
  116. Uthaya S, Thomas EL, Hamilton G, et al. Altered adiposity after extremely preterm birth. Pediatric Research. 2005;57:211–215
  117. Yau KI, Chang MH. Growth and body composition of preterm, small-for-gestational-age infants at a postmenstrual age of 37–40 weeks. Early Human Development. 1993;33:117–131
  118. Bazaes RA, Alegria A, Pittaluga E, et al. Determinants of insulin sensitivity and secretion in very-low-birth-weight children. The Journal of Clinical Endocrinology and Metabolism. 2004;89:1267–1272
  119. Victora CG, Barros FC, Horta BL, et al. Short-term benefits of catch-up growth for small-for-gestational-age infants. International Journal of Epidemiology. 2001;30:1325–1330
  120. Lucas A, Morley R, Cole TJ. Randomised trial of early diet in preterm babies and later intelligence quotient. BMJ. 1998;317:1481–1487

PII: S1521-690X(07)00092-9

doi: 10.1016/j.beem.2007.10.001

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 1 , Pages 41-55 , February 2008

Article Tools

* Image Usage & Resolution